Aquaculture is vital to global food security; however, the intensification of farming systems has increased the impact of infectious diseases—particularly viral outbreaks, for which treatment options remain limited. Consequently, vaccination is a cornerstone of fish health management, though its efficacy depends on precise antigen selection, effective immune targeting, and compatibility with teleost immune responses. Under the Singapore Food Story (SFS) 1.0 research programme, we evaluated epitope-based vaccine strategies against Scale Drop Disease Virus (SDDV), which causes severe outbreaks and 40–70% mortality in Asian seabass (Lates calcarifer) . In a controlled challenge study involving 141 juvenile fish across six experimental groups, animals were immunized with vaccines targeting B-cell epitopes, T-cell epitopes, a combined B/T epitope formulation, or a traditional subunit antigen. Following an intraperitoneal challenge with SDDV, survival outcomes differed markedly: the combined B/T epitope vaccine conferred the highest level of protection, outperforming both the T-cell-only and B-cell-only formulations. In contrast, the subunit vaccine provided minimal protection and exhibited higher mortality than unvaccinated controls, highlighting the risks of non-rational antigen selection in fish. Building on these findings, SFS 2.0 focuses on mechanism-driven vaccine development supported by new immunological assays. We established a continuous Asian seabass cell line to enable reproducible SDDV propagation, TCID50-based infectivity measurements, and functional neutralization and T-cell assays. Utilizing these data alongside structural biology approaches, we are currently designing multi-epitope and modular vaccine constructs. Furthermore, vaccine-induced antibody responses can now be quantified using an adapted SDDV neutralization assay, allowing for the functional comparison and ranking of candidates beyond simple survival metrics.
Collectively, these data suggest that epitope-based vaccines are not merely "reduced" versions of traditional vaccines; rather, they require highly informed antigen selection to be effective and can be applied to any pathogens. Moving forward, integrating epitope-informed design with improvements in diagnostics and husbandry will be essential for developing resilient, sustainable aquaculture systems. The SFS programme provides a robust framework for bridging fundamental immunological understanding with applied vaccine development.